Translate to...

Johnson Johnson starts human safety trial for its COVID-19 vaccine candidate

Johnson  Johnson starts human safety trial for its COVID-19 vaccine candidate

When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study published in the journal Nature.